Company intelligence / Profile preview

Troikaa Pharmaceuticals

Ahmedabad, Gujarat, Indiatroikaa.com ↗

Ownership: Private
Employees: ~3500
Development stage: Other

Overview

Troikaa has a strong commercial presence with patented and proprietary drug delivery technologies. Its lead brands like Dynapar AQ/Dynapar QPS have significant market share in pain management. The company has launched the world’s first intranasal methylcobalamin spray for vitamin B12 deficiency using its patented Nasomax technology. Three more products were reported to be at the clinical trial stage as of early/mid–2020s.

Therapeutic areas: HematologyGastroenterologyNeurologyOther
Modalities: Small moleculeBiologicNovel Drug Delivery Systems (NDDS)
Industry: Biotech

Drug pipeline

2 assets

Nitro G

1 more asset in the full pipeline.

Request access →

Partnerships

BRD Medilabs

Beyond the preview

Go deeper on Troikaa Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Troikaa Pharmaceuticals.

Explore the full profile